Tag: Jubilant
Jubilant Bhartia Foundation & McGill University collaborate to launch CoE in...
This partnership will leverage McGill University’s research led AI ecosystem to create an innovative program that integrates strong theoretical foundations with practical implementation
Jubilant Biosys seals deal with Pierre Fabre SA
To acquire R&D center at Saint-Julien-en-Genevois, France
Jubilant Biosys to expand its footprint in Europe, add drug discovery...
Through a series of collaborative and acquisition deals, company aims to develop a unique delivery model tailored for its customers
Jubilant launches JUBI-R, its generic version of COVID-19 drug remdesivir in...
Jubilant Generics, a subsidiary of Jubilant Life Sciences has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of INR 4,700 per vial of 100 mg (lyophilized injection)........................
Jubilant announces price increase of 10% for Vitamin B3
Jubilant Life Sciences is the second largest producer of Vitamin B3 globally.................................
Jubilant Life Sciences records net profit of 2% at Rs 152...
For the entire 2017-18 financial year, the company posted a net profit of Rs 634.42 crore as against Rs 574.62 crore in 2016-17..........
Jubilant Life Sciences reports record performance in 3rd quarter of ...
The company registered its highest ever revenues at Rs 2,068 crore with profits upto 42 percent year on year.......



























































